This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Kentucky Research Foundation. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Innovations in Cancer Treatment by Caixia Hou
Introduction
Caixia Hou is a prominent inventor based in Lexington, KY (US). She has made significant contributions to the field of cancer research through her innovative work on Mithramycin derivatives. With a total of 2 patents, her research focuses on developing compounds that exhibit increased selectivity and anti-cancer activity.
Latest Patents
Caixia Hou's latest patents include the development of Mithramycin (MTM) short side chain ketone (SK) derivatives and MTM short side chain diketone (SDK) derivatives. These derivatives are designed to be useful in the treatment of cancer or neuro-diseases associated with an aberrant erythroblast transformation-specific transcription factor. The unique MTM SK and MTM SDK derivatives demonstrate increased selectivity toward the ETS transcription factor. Additionally, she has developed Mithramycin side chain carboxylic acid (MTM-SA) derivatives, which include substituted amino acid derivatives, substituted amino acid dipeptide derivatives, or unsubstituted dipeptide derivatives. The MTM-SA derivatives also show promise in treating cancer or neuro-diseases linked to the same transcription factor, with enhanced selectivity toward the ETS transcription factor.
Career Highlights
Caixia Hou is affiliated with the University of Kentucky Research Foundation, where she conducts her research. Her work has garnered attention for its potential impact on cancer treatment and neuro-disease therapies.
Collaborations
Some of her notable coworkers include Markos Leggas and Joseph M Eckenrode, who contribute to her research efforts and innovations.
Conclusion
Caixia Hou's innovative work in developing Mithramycin derivatives represents a significant advancement in cancer treatment research. Her contributions are paving the way for new therapeutic options in the fight against cancer and neuro-diseases.